Provenge
Payments companies reported to CMS as associated with Provenge. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Provenge, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Provenge
These are the largest totals companies reported as associated with Provenge. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Judd Moul | Durham, NC | Urology | $145,954.42 |
| Jonathan Hamilton | Greenville, NC | Urology | $103,603.69 |
| Jim Hsiang | Corpus Christi, TX | Radiation Oncology | $80,404.31 |
| William Berry | Raleigh, NC | Hematology & Oncology | $67,456.20 |
| Vahan Kassabian | Roswell, GA | Urology | $66,115.30 |
| Paul Eber | Germantown, TN | Urology | $64,936.21 |
| Vincent Bivins | Homewood, AL | Urology | $55,337.15 |
| Paul Dato | La Mesa, CA | Urology | $52,107.91 |
| Paul Sieber | Lancaster, PA | Urology | $44,140.65 |
| Mahdi Taha | Boca Raton, FL | Medical Oncology | $37,429.69 |
Prescribed Provenge?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.